Robert Redfield - 08 Mar 2026 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role: Chief Medical Officer
Signature: /s/ Robert Redfield
Issuer symbol: TRAW
Transactions as of: 08 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 10 Mar 2026, 19:15:00 UTC
Previous filing: 16 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Redfield Robert	Chief Medical Officer	C/O TRAWS PHARMA, INC., 12 PENNS TRAIL, NEWTON	/s/ Robert Redfield	10 Mar 2026	0002018274

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TRAW	Stock Option (right to buy)	Award		+108,854		$0.000000^*	108,854	08 Mar 2026	Common Stock	108,854	$1.60	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date.